Literature DB >> 33419602

Health economic analyses of the justice community opioid innovation network (JCOIN).

Sean M Murphy1, Neda Laiteerapong2, Mai T Pho2, Danielle Ryan3, Iván Montoya4, Theresa I Shireman5, Elbert Huang2, Kathryn E McCollister4.   

Abstract

The Justice Community Opioid Innovation Network (JCOIN) will generate real-world evidence to address the unique needs of people with opioid use disorder (OUD) in justice settings. Evidence regarding the economic value of OUD interventions in justice populations is limited. Moreover, the variation in economic study designs is a barrier to defining specific interventions as broadly cost-effective. The JCOIN Health Economics Analytic Team (HEAT) has worked closely with the Measures Committee to incorporate common economic measures and instruments across JCOIN studies, which will: a) ensure rigorous economic evaluations within each trial; b) enhance comparability of findings across studies; and c) allow for cross-study analyses of trials with similar designs/settings (e.g., pre-reentry MOUD), to assess questions beyond the scope of a single study, while controlling for and evaluating the effect of intervention-, organizational-, and population-level characteristics. We describe shared trial characteristics relevant to the economic evaluations, and discuss potential cross-study economic analyses.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cost-effective; Economics; JCOIN; Justice populations; Opioid use disorder

Mesh:

Substances:

Year:  2021        PMID: 33419602      PMCID: PMC8255321          DOI: 10.1016/j.jsat.2020.108262

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  25 in total

1.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.

Authors:  Don Husereau; Michael Drummond; Stavros Petrou; Chris Carswell; David Moher; Dan Greenberg; Federico Augustovski; Andrew H Briggs; Josephine Mauskopf; Elizabeth Loder
Journal:  Value Health       Date:  2013 Mar-Apr       Impact factor: 5.725

2.  Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.

Authors:  Noa Krawczyk; Caroline E Picher; Kenneth A Feder; Brendan Saloner
Journal:  Health Aff (Millwood)       Date:  2017-12       Impact factor: 6.301

3.  Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future.

Authors:  Ali Jalali; Danielle A Ryan; Kathryn E McCollister; Lisa A Marsch; Bruce R Schackman; Sean M Murphy
Journal:  J Subst Abuse Treat       Date:  2020-03

4.  Improving retention across the OUD service cascade upon reentry from jail using Recovery Management Checkups-Adaptive (RMC-A) experiment.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Dennis P Watson
Journal:  J Subst Abuse Treat       Date:  2020-12-11

5.  The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail.

Authors:  Benjamin A Howell; Lisa Puglisi; Katie Clark; Carmen Albizu-Garcia; Evan Ashkin; Tyler Booth; Lauren Brinkley-Rubinstein; David A Fiellin; Aaron D Fox; Kathleen F Maurer; Hsiu-Ju Lin; Kathryn McCollister; Sean Murphy; Diane S Morse; Shira Shavit; Karen Wang; Tyler Winkelman; Emily A Wang
Journal:  J Subst Abuse Treat       Date:  2021-01-29

6.  Using implementation interventions and peer recovery support to improve opioid treatment outcomes in community supervision: Protocol.

Authors:  Rosemarie A Martin; L A R Stein; Damaris J Rohsenow; Steven Belenko; Linda E Hurley; Jennifer G Clarke; Lauren Brinkley-Rubinstein
Journal:  J Subst Abuse Treat       Date:  2021-03-12

Review 7.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26

8.  Lived Experience in New Models of Care for Substance Use Disorder: A Systematic Review of Peer Recovery Support Services and Recovery Coaching.

Authors:  David Eddie; Lauren Hoffman; Corrie Vilsaint; Alexandra Abry; Brandon Bergman; Bettina Hoeppner; Charles Weinstein; John F Kelly
Journal:  Front Psychol       Date:  2019-06-13

9.  Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials.

Authors:  Sean M Murphy; Philip J Jeng; Sabrina A Poole; Ali Jalali; Frank J Vocci; Michael S Gordon; George E Woody; Daniel Polsky
Journal:  Addict Sci Clin Pract       Date:  2020-04-22

10.  Validity of self-reported criminal justice system involvement in substance abusing women at five-year follow-up.

Authors:  Irene Jansson; Morten Hesse; Mats Fridell
Journal:  BMC Psychiatry       Date:  2008-01-07       Impact factor: 3.630

View more
  1 in total

1.  Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort.

Authors:  Jake R Morgan; Alexander Y Walley; Sean M Murphy; Avik Chatterjee; Scott E Hadland; Joshua Barocas; Benjamin P Linas; Sabrina A Assoumou
Journal:  Drug Alcohol Depend       Date:  2021-05-21       Impact factor: 4.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.